Abstract:The demonstration of metabolically active brown adipose tissue (BAT) in humans primarily using positron emission tomography coupled to computed tomography (PET/CT) with the glucose tracer 18-fluorodeoxyglucose (18FDG) has renewed the interest of the scientific and medical community in the possible role of BAT as a target for the prevention and treatment of obesity and type 2 diabetes (T2D). Here, we offer a comprehensive review of BAT energy metabolism in humans. Considerable advances in methods to measure BAT energy metabolism, including nonesterified fatty acids (NEFA), chylomicron-triglycerides (TG), oxygen, Krebs cycle rate, and intracellular TG have led to very good quantification of energy substrate metabolism per volume of active BAT in vivo. These studies have also shown that intracellular TG are likely the primary energy source of BAT upon activation by cold. Current estimates of BAT's contribution to energy expenditure range at the lower end of what would be potentially clinically relevant if chronically sustained. Yet, 18FDG PET/CT remains the gold-standard defining method to quantify total BAT volume of activity, used to calculate BAT's total energy expenditure. Unfortunately, BAT glucose metabolism better reflects BAT's insulin sensitivity and blood flow. It is now clear that most glucose taken up by BAT does not fuel mitochondrial oxidative metabolism and that BAT glucose uptake can therefore be disconnected from thermogenesis. Furthermore, BAT thermogenesis is efficiently recruited upon repeated cold exposure, doubling to tripling its total oxidative capacity, with reciprocal reduction of muscle thermogenesis. Recent data suggest that total BAT volume may be much larger than the typically observed 50-150 ml with 18FDG PET/CT. Therefore, the current estimates of total BAT thermogenesis, largely relying on total BAT volume using 18FDG PET/CT, may underestimate the true contribution of BAT to total energy expenditure. Quantification of the contribution of BAT to energy expenditure begs for the development of more integrated whole body in vivo methods.

Tracers and Imaging of Fatty Acid and Energy Metabolism of Human Adipose Tissues

Two-photon Excited Fluorescence of Intrinsic Fluorophores Enables Label-Free Assessment of Adipose Tissue Function

Molecular Imaging of Brown Adipose Tissue Mass

A synopsis of brown adipose tissue imaging modalities for clinical research

ADIPOSITY-RELATED CANCER AND FUNCTIONAL IMAGING OF BROWN ADIPOSE TISSUE

Imaging of adipose tissue

Brown Adipose Tissue—A Translational Perspective

Non-invasive Imaging Methods for Brown Adipose Tissue Detection and Function Evaluation.

Preclinical in Vivo Imaging for Brown Adipose Tissue

Anatomical and Functional Assessment of Brown Adipose Tissue by Magnetic Resonance Imaging

Brown Adipose Tissue Energy Metabolism in Humans

Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT

An Adipose Tissue Atlas: an Image-Guided Identification of Human-like BAT and Beige Depots in Rodents.

Brown Adipose Tissue Mapping in Rats with Combined Intermolecular Double‐quantum Coherence and Dixon Water–fat MRI

PET Imaging of Human Brown Adipose Tissue with the TSPO Tracer [ 11 C]PBR28

Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body

Brown Adipose Tissue Response Dynamics: In Vivo Insights with the Voltage Sensor 18F-Fluorobenzyl Triphenyl Phosphonium

Human thermogenic adipose tissue

Multiscale Imaging of Brown Adipose Tissue in Living Mice/Rats with Fluorescent Polymer Dots.

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Accurate quantification of brown adipose tissue mass by xenon-enhanced computed tomography